Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine; Saint Louis, MO 63130, USA.
Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN 55905, USA.
J Clin Endocrinol Metab. 2022 Feb 17;107(3):e1221-e1230. doi: 10.1210/clinem/dgab724.
Interpretation of dexamethasone suppression test (DST) may be influenced by dexamethasone absorption and metabolism and by the altered cortisol binding.
We aimed to determine the normal ranges of free cortisol during DST in participants without adrenal disorders and to identify the population of patients where post-DST free cortisol measurements add value to the diagnostic workup.
Cross-sectional study conducted in a tertiary medical center.
Adult volunteers without adrenal disorders (n = 168; 47 women on oral contraceptive therapy [OCP], 66 women not on OCP, 55 men) and patients undergoing evaluation for hypercortisolism (n = 196; 16 women on OCP).
Post-DST dexamethasone and free cortisol (mass spectrometry) and total cortisol (immunoassay).
Reference range for post-DST free cortisol, diagnostic accuracy of post-DST total cortisol.
Adequate dexamethasone concentrations (≥0.1 mcg/dL) were seen in 97.6% volunteers and 96.3% patients. Only 25.5% of women volunteers on OCP had abnormal post-DST total cortisol (>1.8 mcg/dL). In volunteers, the upper post-DST free cortisol range was 48 ng/dL in men and women not on OCP, and 79 ng/dL in women on OCP. When compared with post-DST free cortisol, diagnostic accuracy of post-DST total cortisol was 87.3% (95% CI, 81.7-91.7); all false-positive results occurred in patients with post-DST cortisol between 1.8 and 5 mcg/dL. OCP use was the only factor associated with false-positive results (21.1% vs 4.9%, P = 0.02).
Post-DST free cortisol measurements are valuable in patients with optimal dexamethasone concentrations and post-DST total cortisol between 1.8 and 5 mcg/dL.
地塞米松抑制试验(DST)的解读可能受到地塞米松的吸收和代谢以及皮质醇结合的改变的影响。
我们旨在确定无肾上腺疾病参与者 DST 期间游离皮质醇的正常范围,并确定 DST 后游离皮质醇测量对诊断评估有价值的患者人群。
在一家三级医疗中心进行的横断面研究。
无肾上腺疾病的成年志愿者(n=168;47 名口服避孕药治疗[OCP]的女性,66 名未服用 OCP 的女性,55 名男性)和接受高皮质醇血症评估的患者(n=196;16 名服用 OCP 的女性)。
DST 后地塞米松和游离皮质醇(质谱法)和总皮质醇(免疫测定法)。
DST 后游离皮质醇的参考范围,DST 后总皮质醇的诊断准确性。
97.6%的志愿者和 96.3%的患者地塞米松浓度足够(≥0.1 mcg/dL)。仅 25.5%的服用 OCP 的女性志愿者 DST 后总皮质醇异常(>1.8 mcg/dL)。在志愿者中,未服用 OCP 的男性和女性志愿者的 DST 后游离皮质醇上限范围为 48 ng/dL,服用 OCP 的女性为 79 ng/dL。与 DST 后游离皮质醇相比,DST 后总皮质醇的诊断准确性为 87.3%(95%CI,81.7-91.7);所有假阳性结果均发生在 DST 后皮质醇在 1.8 和 5 mcg/dL 之间的患者中。OCP 使用是唯一与假阳性结果相关的因素(21.1%比 4.9%,P=0.02)。
在最佳地塞米松浓度和 DST 后皮质醇在 1.8 和 5 mcg/dL 之间的患者中,DST 后游离皮质醇测量值具有重要价值。